Categories: aggregated

New THC-CBD Pill for MS and Huntington’s Disease May Be First to Benefit from Biden’s New Marijuana Research Bill

In related news, President Biden signed the Marijuana Research and Expansion Act into law. This will speed up researchers’ bids for DEA schedule 1 registration authorization to undertake these trials. After seven hard years of waiting, the MMJ group of firms can finish their mission of performing clinical studies on Huntington’s Disease and Multiple Sclerosis. MMJ has received FDA Orphan Designation for its Huntington’s disease clinical trials.

Jason

Share
Published by
Jason

Recent Posts

Cannabis in Germany: Club Licenses Stall While Medical Access Shrinks

Germany has received nearly 900 applications for cannabis cultivation associations, but only just over half…

1 hour ago

So Will the Hemp Ban Be Delayed or Not? Tensions Rise Between the GOP and the White House

A Senate stopgap funding bill would delay the federal prohibition on most hemp-derived THC products…

1 hour ago

Rick Ross Doesn’t Want Dispensary Weed

He smokes in boardrooms, but he’s still on that underground frequency. This content originally appeared…

1 hour ago

No, Fox News, Cannabis Was Never ‘Legalized’ — It Was Patchworked, Taxed to Death, and Blamed for Prohibition’s Own Failures

Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against…

1 hour ago

One Plant, Seven Perspectives: The Art From Our 50th Anniversary Print Issue

For our 50th anniversary, we handed the plant to the artists making its most striking…

1 day ago

Legal Weed Makes Businesses More Profitable? The Unintended Consequence Nobody Was Modeling for with Legalization

Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…

1 day ago